Nasser Hanna

  • 8113 Citations
  • 41 h-Index
19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Filter
Article
2020

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14-179

Durm, G. A., Jabbour, S. K., Althouse, S. K., Liu, Z., Sadiq, A. A., Zon, R. T., Jalal, S. I., Kloecker, G. H., Williamson, M. J., Reckamp, K. L., Langdon, R. M., Kio, E. A., Gentzler, R. D., Adesunloye, B. A., Harb, W. A., Walling, R. V., Titzer, M. L. & Hanna, N. H., Oct 1 2020, In : Cancer. 126, 19, p. 4353-4361 9 p.

Research output: Contribution to journalArticle

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases

Kalra, M., Adra, N., Hanna, N., Abonour, R. & Einhorn, L. H., Mar 15 2020, In : Cancer. 126, 6, p. 1202-1207 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Lung Cancer Screening Knowledge Among Internal Medicine Residents in a University Program

Urrutia Argueta, S. & Hanna, N., Jan 1 2020, (Accepted/In press) In : Journal of Cancer Education.

Research output: Contribution to journalArticle

3 Scopus citations

The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy

Khanal, N., Ahmed, S. S., Kalra, M., Miller, T. J., Brames, M. J., Stump, T. E., Monahan, P., Hanna, N. H. & Einhorn, L. H., Jul 1 2020, In : Supportive Care in Cancer. 28, 7, p. 3165-3170 6 p.

Research output: Contribution to journalArticle

Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update

Hanna, N. H., Schneider, B. J., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Gaspar, L. E., Haddad, R. Y., Hesketh, P. J., Jain, D., Jaiyesimi, I., Johnson, D. H., Leighl, N. B., Phillips, T., Riely, G. J., Robinson, A. G., Rosell, R., Schiller, J. H., Singh, N., Spigel, D. R. & 3 others, Stabler, J. O., Tashbar, J. & Masters, G., 2020, In : Journal of Clinical Oncology. 38, 14, p. 1608-1632 25 p.

Research output: Contribution to journalArticle

19 Scopus citations

Therapy for stage IV Non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update summary

Hanna, N. H., Temin, S. & Masters, G., 2020, In : JCO Oncology Practice. 16, 8, p. E844-E848

Research output: Contribution to journalArticle

2019
5 Scopus citations
2018
3 Scopus citations

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma

Raad, S., Hanna, N., Jalal, S., Bendaly, E., Zhang, C., Nuguru, S., Oueini, H. & Diab, K., Aug 1 2018, In : Southern Medical Journal. 111, 8, p. 484-488 5 p.

Research output: Contribution to journalArticle

1 Scopus citations
6 Scopus citations

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors

Albany, C., Adra, N., Snavely, A. C., Cary, C., Masterson, T. A., Foster, R. S., Kesler, K., Ulbright, T. M., Cheng, L., Chovanec, M., Taza, F., Ku, K., Brames, M. J., Hanna, N. H. & Einhorn, L. H., Feb 1 2018, In : Annals of Oncology. 29, 2, p. 341-346 6 p.

Research output: Contribution to journalArticle

33 Scopus citations

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: A Hoosier Cancer Research Network Study GU14-206

Adra, N., Einhorn, L. H., Althouse, S. K., Ammakkanavar, N. R., Musapatika, D., Albany, C., Vaughn, D. & Hanna, N. H., Jan 1 2018, In : Annals of Oncology. 29, 1, p. 209-214 6 p.

Research output: Contribution to journalArticle

57 Scopus citations
5 Scopus citations

Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers

Carter-Harris, L., Slaven, J. E., Monahan, P. O., Shedd-Steele, R., Hanna, N. & Rawl, S. M., Jun 2018, In : Preventive Medicine Reports. 10, p. 49-54 6 p.

Research output: Contribution to journalArticle

20 Scopus citations
2017

A randomized, double-blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive-stage small cell lung cancer: Hoosier Cancer Research Network LUN06-113

Sanborn, R. E., Patel, J. D., Masters, G. A., Jayaram, N., Stephens, A., Guarino, M., Misleh, J., Wu, J. & Hanna, N., Jan 1 2017, In : Cancer. 123, 2, p. 303-311 9 p.

Research output: Contribution to journalArticle

14 Scopus citations
59 Scopus citations

Lung cancer screening: what do long-term smokers know and believe?

Carter-Harris, L., Ceppa, D. K. P., Hanna, N. & Rawl, S. M., Feb 1 2017, In : Health Expectations. 20, 1, p. 59-68 10 p.

Research output: Contribution to journalArticle

47 Scopus citations

Phase i Study of Amrubicin and Cyclophosphamide in Patients with Advanced Solid Organ Malignancies

Jalal, S. I., Hanna, N., Zon, R., Masters, G. A., Borghaei, H., Koneru, K., Badve, S., Prasad, N., Somaiah, N., Wu, J., Yu, Z. & Einhorn, L., Jan 1 2017, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 4, p. 329-335 7 p.

Research output: Contribution to journalArticle

Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial

Lesaffre, E., Edelman, M. J., Hanna, N. H., Park, K., Thatcher, N., Willemsen, S., Gaschler-Markefski, B., Kaiser, R. & Manegold, C., Jul 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 7, p. 1419-1426 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

Systemic therapy for stage IV non–small-cell lung cancer: American Society of clinical oncology clinical practice guideline update

Hanna, N., Johnson, D., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., Riely, G. J., Schiller, J. H., Schneider, B. J., Smith, T. J., Tashbar, J., Biermann, W. A. & Masters, G., Oct 20 2017, In : Journal of Clinical Oncology. 35, 30, p. 3484-3515 32 p.

Research output: Contribution to journalArticle

242 Scopus citations

Targeting FGFR in Squamous Cell Carcinoma of the Lung

Hashemi-Sadraei, N. & Hanna, N., Jul 6 2017, (Accepted/In press) In : Targeted Oncology. p. 1-15 15 p.

Research output: Contribution to journalArticle

6 Scopus citations

Testicular cancer: The usage of central review for pathology diagnosis of orchiectomy specimens

Harari, S. E., Sassoon, D. J., Priemer, D. S., Jacob, J. M., Eble, J. N., Caliò, A., Grignon, D. J., Idrees, M., Albany, C., Masterson, T. A., Hanna, N. H., Foster, R. S., Ulbright, T. M., Einhorn, L. H. & Cheng, L., Oct 2017, In : Urologic Oncology: Seminars and Original Investigations. 35, 10, p. 605.e9-605.e16

Research output: Contribution to journalArticle

7 Scopus citations

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

Gaschler-Markefski, B., Sikken, P., Heymach, J. V., Gottfried, M., Mellemgaard, A., Novello, S., Gann, C. N., Barrueco, J., Reck, M., Hanna, N. H. & Kaiser, R., Apr 2017, In : ESMO Open. 2, 1, e000102.

Research output: Contribution to journalArticle

8 Scopus citations

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer

Adra, N., Cheng, L., Hanna, N. H. & Durm, G., Jun 2017, In : Clinical Genitourinary Cancer. 15, 3, p. e489-e491

Research output: Contribution to journalArticle

2016
3 Scopus citations

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors

Necchi, A., Pond, G. R., Nicolai, N., Giannatempo, P., Raggi, D., Adra, N., Hanna, N., Salvioni, R., Einhorn, L. & Albany, C., May 26 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

10 Scopus citations

Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers

Radovich, M., Kiel, P. J., Nance, S. M., Niland, E. E., Parsley, M. E., Ferguson, M. E., Jiang, G., Ammakkanavar, N. R., Einhorn, L. H., Cheng, L., Nassiri, M., Davidson, D. D., Rushing, D. A., Loehrer, P. J., Pili, R., Hanna, N., Thomas Callaghan, J., Skaar, T. C., Helft, P. R., Shahda, S. & 2 others, O'Neil, B. H. & Schneider, B. P., 2016, In : Oncotarget. 7, 35, p. 56491-56500 10 p.

Research output: Contribution to journalArticle

38 Scopus citations

Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial

Hanna, N. H., Kaiser, R., Sullivan, R. N., Aren, O. R., Ahn, M. J., Tiangco, B., Voccia, I., Pawel, J. V., Kovcin, V., Agulnik, J., Gaschler-Markefski, B., Barrueco, J., Sikken, P., Schloss, C. & Kim, J. H., Dec 1 2016, In : Lung Cancer. 102, p. 65-73 9 p.

Research output: Contribution to journalArticle

46 Scopus citations

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study

Adra, N., Albany, C., Brames, M. J., Case-Eads, S., Johnson, C. S., Liu, Z., Fausel, C. A., Breen, T., Hanna, N. H., Hauke, R. J., Picus, J. & Einhorn, L. H., Jul 1 2016, In : Supportive Care in Cancer. 24, 7, p. 2837-2842 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

Prognostic factors in patients with poor-risk germ-cell tumors: A retrospective analysis of the Indiana University experience from 1990 to 2014

Adra, N., Althouse, S. K., Liu, H., Brames, M. J., Hanna, N. H., Einhorn, L. H. & Albany, C., May 1 2016, In : Annals of Oncology. 27, 5, p. 875-879 5 p., 10.1093/annonc/mdw052.

Research output: Contribution to journalArticle

22 Scopus citations
26 Scopus citations
2015

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

Blumenschein, G. R., Smit, E. F., Planchard, D., Kim, D. W., Cadranel, J., De Pas, T., Dunphy, F., Udud, K., Ahn, M. J., Hanna, N. H., Kim, J. H., Mazieres, J., Kim, S. W., Baas, P., Rappold, E., Redhu, S., Puski, A., Wu, F. S. & Jänne, P. A., May 1 2015, In : Annals of Oncology. 26, 5, p. 894-901 8 p., mdv072.

Research output: Contribution to journalArticle

132 Scopus citations
38 Scopus citations
3 Scopus citations

Electronic nicotine delivery systems: A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Brandon, T. H., Goniewicz, M. L., Hanna, N. H., Hatsukami, D. K., Herbst, R. S., Hobin, J. A., Ostroff, J. S., Shields, P. G., Toll, B. A., Tyne, C. A., Viswanath, K. & Warren, G. W., Mar 10 2015, In : Journal of Clinical Oncology. 33, 8, p. 952-963 12 p.

Research output: Contribution to journalArticle

70 Scopus citations

Electronic nicotine delivery systems: A policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology

Brandon, T. H., Goniewicz, M. L., Hanna, N. H., Hatsukami, D. K., Herbst, R. S., Hobin, J. A., Ostroff, J. S., Shields, P. G., Toll, B. A., Tyne, C. A., Viswanath, K. & Warren, G. W., Feb 1 2015, In : Clinical Cancer Research. 21, 3, p. 514-525 12 p.

Research output: Contribution to journalArticle

51 Scopus citations
18 Scopus citations
2014

Barriers to mental health service use and preferences for addressing emotional concerns among lung cancer patients

Mosher, C. E., Winger, J. G., Hanna, N., Jalal, S. I., Fakiris, A. J., Einhorn, L. H., Birdas, T. J., Kesler, K. A. & Champion, V. L., Jul 2014, In : Psycho-Oncology. 23, 7, p. 812-819 8 p.

Research output: Contribution to journalArticle

17 Scopus citations

Nintedanib for the treatment of non-small-cell lung cancer

Rashdan, S. & Hanna, N., Apr 2014, In : Expert opinion on pharmacotherapy. 15, 5, p. 729-739 11 p.

Research output: Contribution to journalArticle

10 Scopus citations

Targeting multiple angiogenic pathways simultaneously: Experience with nintedanib in non-small-cell lung cancer

Durm, G. & Hanna, N., May 2014, In : Future Oncology. 10, 7, p. 1167-1173 7 p.

Research output: Contribution to journalArticle

4 Scopus citations
2013

A Phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier oncology group G05-92

Becerra, C. R., Hanna, N., Mccollum, A. D., Becharm, N., Timmerman, R. D., Dimaio, M., Kesler, K. A., Yu, M., Yan, T. & Choy, H., Nov 2013, In : Journal of Thoracic Oncology. 8, 11, p. 1425-1429 5 p.

Research output: Contribution to journalArticle

16 Scopus citations

Distressed family caregivers of lung cancer patients: An examination of psychosocial and practical challenges

Mosher, C. E., Jaynes, H. A., Hanna, N. & Ostroff, J. S., Feb 1 2013, In : Supportive Care in Cancer. 21, 2, p. 431-437 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

Economic and social changes among distressed family caregivers of lung cancer patients

Mosher, C. E., Champion, V. L., Azzoli, C. G., Hanna, N., Jalal, S. I., Fakiris, A. J., Birdas, T. J., Okereke, I. C., Kesler, K. A., Einhorn, L. H., Monahan, P. O. & Ostroff, J. S., Mar 1 2013, In : Supportive Care in Cancer. 21, 3, p. 819-826 8 p.

Research output: Contribution to journalArticle

23 Scopus citations

Erlotinib and bevacizumab in newly diagnosed performance status 2 or elderly patients with nonsquamous non-small-cell lung cancer, a phase II study of the hoosier oncology group: LUN04-77

Riggs, H., Jalal, S. I., Baghdadi, T. A., Bhatia, S., McClean, J., Johnson, C., Yu, M., Taber, D., Harb, W. & Hanna, N., 2013, In : Clinical Lung Cancer. 14, 3, p. 224-229 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours

Soria, J. C., Baselga, J., Hanna, N., Laurie, S. A., Bahleda, R., Felip, E., Calvo, E., Armand, J. P., Shepherd, F. A., Harbison, C. T., Berman, D., Park, J. S., Zhang, S., Vakkalagadda, B., Kurland, J. F., Pathak, A. K. & Herbst, R. S., May 2013, In : European Journal of Cancer. 49, 8, p. 1815-1824 10 p.

Research output: Contribution to journalArticle

16 Scopus citations

Support service use and interest in support services among distressed family caregivers of lung cancer patients

Mosher, C. E., Champion, V. L., Hanna, N., Jalal, S. I., Fakiris, A. J., Birdas, T. J., Okereke, I. C., Kesler, K. A., Einhorn, L. H., Given, B. A., Monahan, P. O. & Ostroff, J. S., Jul 2013, In : Psycho-Oncology. 22, 7, p. 1549-1556 8 p.

Research output: Contribution to journalArticle

29 Scopus citations

Support service use and interest in support services among lung cancer patients

Mosher, C. E., Hanna, N., Jalal, S. I., Fakiris, A. J., Einhorn, L. H., Birdas, T. J., Kesler, K. A. & Champion, V. L., Oct 2013, In : Lung Cancer. 82, 1, p. 162-167 6 p.

Research output: Contribution to journalArticle

8 Scopus citations

Tobacco cessation and control a decade later: American society of clinical oncology policy statement update

Hanna, N., Mulshine, J., Wollins, D. S., Tyne, C. & Dresler, C., Sep 1 2013, In : Journal of Clinical Oncology. 31, 25, p. 3147-3157 11 p.

Research output: Contribution to journalArticle

64 Scopus citations